# Heather Gervais

> Heather Gervais is the chief executive officer of Osso VR, where she is steering immersive procedural training beyond its surgical roots and into health systems, nursing and pharmaceutical education. Her career has consistently joined commercial discipline to healthcare technology, from Epocrates and athenahealth through PWNHealth and Everly Health Solutions, and her public record reveals an operator who treats process improvement, practical adoption and team culture as parts of the same job.

- **Role:** Chief Executive Officer at Osso VR
- **Organizations:** Osso VR, Everly Health Solutions, PWNHealth, athenahealth, Epocrates, Digitas Health, Healthcare Businesswomen's Association
- **Education:** B.S. in Finance, Marketing and Computer Information Systems, La Salle University
- **Known for:** Appointed CEO of Osso VR in August 2024 after serving as its Chief Revenue Officer since 2022., Helped steward the Epocrates side of its integration with athenahealth., Named to the 2013 PharmaVOICE 100 in the Strategists category.

## Career timeline

- **2010** — Served as Vice President, Group Director at Digitas Health, then joined Epocrates in September.
- **2011** — Recognized by the Healthcare Businesswomen's Association as a Rising Star while serving as Epocrates' Vice President of Client Services.
- **2012-2013** — Served as Senior Vice President of Commercial Operations at Epocrates and helped steward the company's integration with athenahealth.
- **2013** — Named to the PharmaVOICE 100 in the Strategists category.
- **2014-2017** — Led commercial operations and sales as a vice president at athenahealth.
- **2016** — Named an HBA Luminary for her leadership in the business of health.
- **2019-2021** — Served as Senior Vice President of Business Development and Account Management at PWNHealth.
- **2021-2022** — Served as Senior Vice President of Everly Health Solutions.
- **2022** — Joined Osso VR as Chief Revenue Officer, responsible for commercial growth and go-to-market refinement.
- **2024** — Appointed Chief Executive Officer of Osso VR, with a mandate to expand partnerships and pursue pharma and health-system markets.
- **2025** — Publicly outlined Osso VR's expansion beyond orthopedics and discussed practical applications of immersive learning in pharma and healthcare training.

## Achievements

- Appointed CEO of Osso VR in August 2024 after serving as its Chief Revenue Officer since 2022.
- Helped steward the Epocrates side of its integration with athenahealth.
- Named to the 2013 PharmaVOICE 100 in the Strategists category.
- Recognized as a Healthcare Businesswomen's Association Rising Star in 2011.
- Recognized as a Healthcare Businesswomen's Association Luminary in 2016.
- Built more than two decades of leadership experience across healthcare and information technology.
- Helped refine Osso VR's go-to-market strategy before becoming CEO.

## Latest updates

- **2025-11** — Osso VR announced a partnership with EBSCO to align its nurse-training scenarios with evidence-based skills and procedure libraries; Gervais shared the announcement publicly.
- **2025-10** — Gervais and Osso VR co-founder Justin Barad attended HLTH 2025 to meet health-system and innovation leaders around workforce readiness.
- **2025-03** — In Pharmaceutical Executive, Gervais discussed VR for pharmaceutical education, field sales, device training and practical deployment in regulated environments.
- **2025-01** — Appeared on the Med Tech Gurus podcast to discuss taking Osso VR from orthopedics into cardiology, aesthetics and pharmaceuticals.
- **2024-08** — Became CEO of Osso VR after nearly two years as Chief Revenue Officer.

## Links

- Website: https://www.ossovr.com
- LinkedIn: https://www.linkedin.com/in/heatheragervais
- Twitter/X: https://x.com/Osso_VR
- YouTube: https://www.youtube.com/c/OssoVR
- Instagram: https://www.instagram.com/osso.vr
- Facebook: https://www.facebook.com/profile.php

---

Profile page: https://yespress.io/heather-gervais
Published by YesPress — https://yespress.io
Last updated: 2026-09-27